Cipher Pharmaceuticals Inc. financial reports, Cipher Pharmaceuticals Inc. annual revenue in 2024. When does Cipher Pharmaceuticals Inc. report revenue?
Cipher Pharmaceuticals Inc. total revenue, net income and dynamics of changes in Canadian dollar today
Cipher Pharmaceuticals Inc. net revenue for today is 5 448 000 $. Net income of Cipher Pharmaceuticals Inc. today amounted to 1 339 000 $. These are the main financial indicators of Cipher Pharmaceuticals Inc.. The financial report chart shows the values from 31/12/2018 to 31/03/2021. The value of the "total revenue of Cipher Pharmaceuticals Inc." on the chart is marked in yellow. The value of Cipher Pharmaceuticals Inc. assets on the online chart is displayed in green bars.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021
7 480 703.28 $
+5.93 % ↑
1 838 594.29 $
+64.09 % ↑
31/12/2020
0 $
-100 % ↓
0 $
-
30/09/2020
6 659 583.50 $
-16.437 % ↓
2 201 095.33 $
-
30/06/2020
6 464 601.88 $
-15.868 % ↓
564 348.21 $
-70.516 % ↓
30/09/2019
7 969 530.44 $
-
-2 853 322.58 $
-
30/06/2019
7 683 923.56 $
-
1 914 115.34 $
-
31/03/2019
7 061 904.73 $
-
1 120 457.76 $
-
31/12/2018
8 776 919.12 $
-
-1 489 824.35 $
-
Show:
to
Cipher Pharmaceuticals Inc. financial report charts
The latest dates of Cipher Pharmaceuticals Inc. financial statements available online: 31/12/2018, 31/12/2020, 31/03/2021. Dates and dates of financial statements are established by the laws of the country where the company operates. The latest financial report of Cipher Pharmaceuticals Inc. is available online for such a date - 31/03/2021. Gross profit Cipher Pharmaceuticals Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Cipher Pharmaceuticals Inc. is 4 527 000 $
Cipher Pharmaceuticals Inc. quarterly report dates
Cost of revenue Cipher Pharmaceuticals Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue Cipher Pharmaceuticals Inc. is 921 000 $ Total revenue Cipher Pharmaceuticals Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Cipher Pharmaceuticals Inc. is 5 448 000 $ Operating income Cipher Pharmaceuticals Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Cipher Pharmaceuticals Inc. is 3 326 000 $
Net income Cipher Pharmaceuticals Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Cipher Pharmaceuticals Inc. is 1 339 000 $ Current assets Cipher Pharmaceuticals Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Cipher Pharmaceuticals Inc. is 22 358 000 $ Total assets Cipher Pharmaceuticals Inc. refers to the total amount of assets owned by a person or entity. Total assets Cipher Pharmaceuticals Inc. is 46 306 000 $
31/03/2021
31/12/2020
30/09/2020
30/06/2020
30/09/2019
30/06/2019
31/03/2019
31/12/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
6 216 068.97 $
-
5 734 107.36 $
5 473 216.46 $
6 964 413.92 $
6 698 030.58 $
6 177 621.89 $
7 830 846.33 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
1 264 634.31 $
-
925 476.14 $
991 385.42 $
1 005 116.52 $
985 892.98 $
884 282.84 $
946 072.79 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
7 480 703.28 $
-
6 659 583.50 $
6 464 601.88 $
7 969 530.44 $
7 683 923.56 $
7 061 904.73 $
8 776 919.12 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
7 969 530.44 $
7 683 923.56 $
7 061 904.73 $
8 776 919.12 $
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
4 566 963.86 $
4 566 963.86 $
3 413 551.46 $
3 646 980.16 $
4 864 928.73 $
3 778 798.72 $
2 061 038.11 $
814 254.23 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
1 838 594.29 $
-
2 201 095.33 $
564 348.21 $
-2 853 322.58 $
1 914 115.34 $
1 120 457.76 $
-1 489 824.35 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
1 373.11 $
1 373.11 $
68 655.50 $
17 850.43 $
376 232.14 $
28 835.31 $
75 521.05 $
201 847.17 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
2 913 739.42 $
-
3 246 032.04 $
2 817 621.72 $
3 104 601.71 $
3 905 124.84 $
5 000 866.62 $
7 962 664.89 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
30 699 993.38 $
27 639 331.19 $
24 904 096.07 $
23 923 695.53 $
21 923 074.26 $
25 416 266.10 $
25 898 227.71 $
31 492 277.85 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
63 583 231.66 $
60 795 818.36 $
63 282 520.57 $
63 180 910.43 $
62 996 913.69 $
72 717 159.38 $
74 290 743.44 $
76 463 003.46 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
18 239 020.13 $
12 552 971.62 $
6 496 183.41 $
11 929 579.68 $
8 720 621.61 $
12 699 894.39 $
10 880 523.64 $
14 221 300.27 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
22 977 622.74 $
23 915 456.87 $
25 023 556.64 $
29 215 661.47 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
28 866 891.53 $
35 523 728.81 $
39 086 949.26 $
42 466 172.97 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
45.82 %
48.85 %
52.61 %
55.54 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
46 586 876.08 $
44 821 056.62 $
45 044 873.55 $
42 801 211.81 $
34 130 022.16 $
37 193 430.57 $
35 203 794.18 $
33 996 830.49 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
2 324 675.23 $
4 536 755.44 $
1 329 170.48 $
2 210 707.10 $
Last revenue report of Cipher Pharmaceuticals Inc. was 31/03/2021. According to last financial report total revenue in Cipher Pharmaceuticals Inc. was 7 480 703.28 Canadian dollar and changed by +5.93% since last year. Net income in Cipher Pharmaceuticals Inc. was 1 838 594.29 $ in last quartal, net income changes to +64.09%.
Current cash Cipher Pharmaceuticals Inc. - the sum of all of the cash a company has on the date of report. Current cash Cipher Pharmaceuticals Inc. is 13 283 000 $
Cipher Pharmaceuticals Inc. stocks data
CPH.TO stock price
Cipher Pharmaceuticals Inc. stock price today, CPH.TO stock quote.
